GeneReach Biotechnology Corp (瑞基海洋) has begun shipping its new dengue fever testing product to Panama.
The Taichung-based company specializes in applied nucleic acid detection technology, including in vitro diagnostic (IVD) devices and reagents.
It initially focused largely on aquaculture testing, but now offers pathogen detection platforms, including equipment and reagents, to multiple industries.
The dengue testing products are a major milestone in its efforts to expand the scope of its business, the firm said on Thursday.
It is also working on broadening applications of its proprietary polymerase chain reaction (PCR) testing platform for livestock and pets, as well as diseases caused by the chikungunya, zika and yellow fever viruses that affect humans, it said.
When the dengue testing products are used along with POCKIT, GeneReach’s handheld diagnostic device, they provide an option for on-site testing to avoid lengthy waits for lab results, the firm said.
It said its dengue testing product is being reviewed by regulators in Taiwan as well as Indonesia and other Southeast Asian nations.
GeneReach chief executive officer Grace Chang (張曉芬) earlier this year said that the US Food and Drug Administration (FDA) is expected to approve the company’s dengue fever testing products in the first half of next year.
The FDA is also reviewing the company’s human-use IVD reagents, which are expected to gain medical device approvals in the first half of next year, Chang said.
According to the WHO, dengue fever is the world’s most prevalent mosquito-borne viral disease, affecting 20 million people across the globe, of which 70 percent reside in Asian nations, while Central and South American countries have been hard-hit, the company said.
GeneReach sees a large market for dengue fever products, as the lack of an effective vaccine makes testing an important facet of disease containment and prevention efforts.
GeneReach’s major customers in China and Thailand have begun requiring it to supply materials instead of finished reagents and testing products — at lower average selling prices — as a trade-off for larger shipping volumes, Chang said.
Larger customers often prefer to manufacture their own testing products from materials supplied by GeneReach, she said.
It typically takes about three years before a new market begins to yield meaningful sales contributions, she added.
GeneReach reported net losses widened by 0.7 percent annually to NT$18.67 million (US$622,126) for the first three quarters of the year, with losses of NT$0.54 per share.
Cumulative revenue for the first 10 months of this year increased 1.54 percent year-on-year to NT$129.799 million, the company’s data showed.
GeneReach shares rose 4.81 percent to NT$20.7 on Friday on the Taipei Exchange. So far this year, the stock has underperformed the TPEx Index by 16.48 percent.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained